Digirad Corporation Comments on Fourth Quarter Progress
January 14 2009 - 6:00AM
PR Newswire (US)
Turnaround Activities Underway; Strong Q4 Cash Flow POWAY, Calif.,
Jan. 14 /PRNewswire-FirstCall/ -- Digirad Corporation
(NASDAQ:DRAD), a leading provider of medical diagnostic imaging
systems and personnel and equipment leasing services to physicians'
offices, hospitals and imaging centers, today announced that
results for the 2008 fourth quarter will show positive progress
toward both organizational and financial turnaround goals laid out
by CEO Todd Clyde following his promotion in to that role in
October 2008. Indications of that progress include: -- The Product
Division was profitable for the year and for the quarter on the
strength of double-digit unit and revenue growth in the fourth
quarter over fourth quarter 2007. The company had established the
goal of profitability for the year in the division at the beginning
of 2008. -- The Centers of Influence (COI) model, which pairs
leading academic centers with a network of community practitioners
to drive growth and utilization, continues to work as the more
established COI locations also showed growth in the quarter over
the prior year. -- Negotiations for the sale or closure of
underperforming hub locations began during the fourth quarter and
are well underway. Those transactions should begin to close during
the next 60 days and are expected to be complete within six months.
The locations generated nearly $7 million of revenue during 2008.
-- The company's operations generated more than $2 million in cash
during the 2008 fourth quarter, bolstering its cash, cash
equivalents and securities to more than $28 million, or
approximately $1.50/share at December 31. Digirad CEO Todd Clyde
said, "The entire organization is focused on achieving positive
cash flow and profitability in the near term while driving
technology progress and improving services utilization to grow
market share over the long run. I have been pleased with the
employee response to our initiatives in the fourth quarter of 2008
and look forward to sharing our progress in greater detail when we
report our full annual results in February." As previously
announced, Clyde will be presenting at J.P. Morgan's 27th Annual
Healthcare Conference being held January 12-15, at the Westin St.
Francis Hotel, San Francisco. His presentation is scheduled to
begin at 11:30 a.m. PT tomorrow, Thursday, January 15. The
presentation will include a discussion of Digirad's business,
strategic focus and outlook. The presentation will also be webcast
live on the events and presentation page of the investors section
of Digirad's web site at http://www.digirad.com/. An archive of the
presentation will be accessible at this site for 90 days. About
Digirad Corporation Digirad provides medical diagnostic imaging
systems and personnel and equipment leasing services to physicians'
offices, hospitals and imaging centers for cardiac, vascular, and
general imaging applications. Digirad's Cardius XPO line of nuclear
imaging cameras use patented solid-state technology and unique
multi (single, dual, triple) head design for superior performance
and advanced features for sharper digital images, faster
processing, compact size, lighter weight for portability, ability
to handle patients up to 500 pounds, and improved patient comfort
compared to standard nuclear cameras. Digirad's 2020tc
general-purpose nuclear imager has a small footprint and may also
be configured for fixed or mobile use to supplement primary
imaging. Digirad's installed base of equipment exceeds 600 systems;
in addition, a mobile fleet of more than 145 nuclear and ultrasound
imaging systems is being used in 21 states, primarily in the
eastern, midwestern and southwestern United States. For more
information, please visit http://www.digirad.com/. Digirad(R),
Digirad Imaging Solutions(R), and Cardius(R) are registered
trademarks of Digirad Corporation. Forward-Looking Statements This
press release contains statements that are forward-looking
statements as defined within the Private Securities Litigation
Reform Act of 1995. These include statements regarding the efficacy
of Digirad's centers of influence model, the status of the
negotiation of the sale or closure of underperforming hub
locations, and the ability to achieve positive cash flow and
profitability, drive technology progress and improve services
utilization to grow market share. These forward-looking statements
are subject to risks and uncertainties that could cause actual
results to differ materially from the statements made, including
the risks associated with changes in business conditions,
technology, customers' business conditions, work force, suppliers,
business prospects, economic outlook, operational policy or
structure, acceptance and use of Digirad's camera systems and
services, reliability, recalls, and other risks detailed in
Digirad's filings with the U.S. Securities and Exchange Commission,
including Annual Report on Form 10-K, Quarterly Reports on Form
10-Q, Current Reports on Form 8-K and other reports. Readers are
cautioned to not place undue reliance on these forward looking
statements, which speak only as of the date hereof. All forward
looking statements are qualified in their entirety by this
cautionary statement, and Digirad undertakes no obligation to
revise or update the forward looking statements contained herein.
Investor Contact: Company Contact: Matt Clawson Todd Clyde Allen
& Caron Chief Executive Officer 949-474-4300 858-726-1600
DATASOURCE: Digirad Corporation CONTACT: Company, Todd Clyde, Chief
Executive Officer of Digirad Corporation, +1-858-726-1600; or
Investors, Matt Clawson of Allen & Caron, +1-949-474-4300, for
Digirad Corporation Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From May 2024 to Jun 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2023 to Jun 2024